173 related articles for article (PubMed ID: 15385106)
1. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors.
Berchuck A; Kohler MF; Hopkins MP; Humphrey PA; Robboy SJ; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC
Gynecol Oncol; 1994 Feb; 52(2):232-6. PubMed ID: 7508877
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of the retinoblastoma gene in ovarian neoplasms and correlation to p53 and K-ras mutations.
Taylor RR; Linnoila RI; Gerardts J; Teneriello MG; Nash JD; Park RC; Birrer MJ
Gynecol Oncol; 1995 Sep; 58(3):307-11. PubMed ID: 7545631
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.
D'Errico A; Garbisa S; Liotta LA; Castronovo V; Stetler-Stevenson WG; Grigioni WF
Mod Pathol; 1991 Mar; 4(2):239-46. PubMed ID: 1646457
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
van der Zee AG; Hollema H; de Jong S; Boonstra H; Gouw A; Willemse PH; Zijlstra JG; de Vries EG
Cancer Res; 1991 Nov; 51(21):5915-20. PubMed ID: 1682037
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and mutation of p53 in epithelial ovarian cancer.
Marks JR; Davidoff AM; Kerns BJ; Humphrey PA; Pence JC; Dodge RK; Clarke-Pearson DL; Iglehart JD; Bast RC; Berchuck A
Cancer Res; 1991 Jun; 51(11):2979-84. PubMed ID: 2032235
[TBL] [Abstract][Full Text] [Related]
7. Loss of basement membrane components by invasive tumors but not by their benign counterparts.
Barsky SH; Siegal GP; Jannotta F; Liotta LA
Lab Invest; 1983 Aug; 49(2):140-7. PubMed ID: 6348406
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.
Monteagudo C; Merino MJ; San-Juan J; Liotta LA; Stetler-Stevenson WG
Am J Pathol; 1990 Mar; 136(3):585-92. PubMed ID: 2156430
[TBL] [Abstract][Full Text] [Related]
9. Blood group substance, CEA, and lectins in ovarian tumors.
Dietel M; Arps H; Hölzel F; Viale G; Dell'Orto P; Kröger A; Niendorf A
Cancer Detect Prev; 1986; 9(5-6):511-20. PubMed ID: 3465441
[TBL] [Abstract][Full Text] [Related]
10. Distribution patterns of type VII collagen in normal and malignant human tissues.
Wetzels RH; Robben HC; Leigh IM; Schaafsma HE; Vooijs GP; Ramaekers FC
Am J Pathol; 1991 Aug; 139(2):451-9. PubMed ID: 1867328
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
[TBL] [Abstract][Full Text] [Related]
12. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival.
Diamantis I; Karamitopoulou E; Perentes E; Zimmermann A
Hepatology; 1995 Sep; 22(3):774-9. PubMed ID: 7657282
[TBL] [Abstract][Full Text] [Related]
13. Tumor cells of malignant fibrous histiocytomas express mRNA for laminin.
Soini Y; Autio-Harmainen H
Am J Pathol; 1991 Nov; 139(5):1061-8. PubMed ID: 1659202
[TBL] [Abstract][Full Text] [Related]
14. Cell kinetics of human epithelial ovarian cancers.
Paradiso A; Silvestrini R; Daidone MG; Coltro Campi C; Grignolio E
Basic Appl Histochem; 1986; 30(2):215-20. PubMed ID: 3017283
[TBL] [Abstract][Full Text] [Related]
15. Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.
Lounis H; Provencher D; Godbout C; Fink D; Milot MJ; Mes-Masson AM
Exp Cell Res; 1994 Dec; 215(2):303-9. PubMed ID: 7526992
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical studies of collagen types I, III and IV distribution and the expression of procollagen III peptide in papillary carcinomas of the thyroid].
Katoh R; Ono S; Sasaki J; Takayama K; Nishio H; Tomichi N; Yagawa K
Gan No Rinsho; 1990 Aug; 36(9):967-72. PubMed ID: 2381052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens.
Grigioni WF; Garbisa S; D'Errico A; Baccarini P; Stetler-Stevenson WG; Liotta LA; Mancini AM
Am J Pathol; 1991 Mar; 138(3):647-54. PubMed ID: 1848041
[TBL] [Abstract][Full Text] [Related]
18. [Flow fluorescence-photometry in ovarian carcinomas with and without effusion].
Krug H; Ebeling K
Zentralbl Gynakol; 1976; 98(7):410-7. PubMed ID: 134608
[TBL] [Abstract][Full Text] [Related]
19. False-negative peritoneal cytology in metastatic ovarian carcinoma.
Pretorius RG; Lee KR; Papillo J; Baker S; Belinson J
Obstet Gynecol; 1986 Nov; 68(5):619-23. PubMed ID: 3763072
[TBL] [Abstract][Full Text] [Related]
20. Small cell carcinoma of the ovary of the hypercalcemic type: p53 protein accumulation and clinicopathologic features.
Seidman JD
Gynecol Oncol; 1995 Nov; 59(2):283-7. PubMed ID: 7590488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
